Your browser doesn't support javascript.
loading
Fibroblast-specific deletion of interleukin-1 receptor-1 reduces adverse cardiac remodeling following myocardial infarction.
Bageghni, Sumia A; Hemmings, Karen E; Yuldasheva, Nadira Y; Maqbool, Azhar; Gamboa-Esteves, Filomena O; Humphreys, Neil E; Jackson, Maj Simonsen; Denton, Christopher P; Francis, Sheila; Porter, Karen E; Ainscough, Justin Fx; Pinteaux, Emmanuel; Drinkhill, Mark J; Turner, Neil A.
Afiliação
  • Bageghni SA; Discovery and Translational Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, United Kingdom.
  • Hemmings KE; Discovery and Translational Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, United Kingdom.
  • Yuldasheva NY; Discovery and Translational Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, United Kingdom.
  • Maqbool A; Discovery and Translational Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, United Kingdom.
  • Gamboa-Esteves FO; Leeds Institute of Cancer and Pathology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
  • Humphreys NE; Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
  • Jackson MS; Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
  • Denton CP; Institute of Immunity and Transplantation, Centre for Rheumatology and Connective Tissue Diseases, University College London and Royal Free Hospital, London, United Kingdom.
  • Francis S; Department of Infection, Immunity & Cardiovascular Disease, Medical School, University of Sheffield, Sheffield, United Kingdom.
  • Porter KE; Discovery and Translational Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, United Kingdom.
  • Ainscough JF; Discovery and Translational Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, United Kingdom.
  • Pinteaux E; Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
  • Drinkhill MJ; Discovery and Translational Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, United Kingdom.
  • Turner NA; Discovery and Translational Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, United Kingdom.
JCI Insight ; 52019 08 08.
Article em En | MEDLINE | ID: mdl-31393855
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Remodelação Ventricular / Receptores Tipo I de Interleucina-1 / Fibroblastos / Infarto do Miocárdio Limite: Animals Idioma: En Revista: JCI Insight Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Remodelação Ventricular / Receptores Tipo I de Interleucina-1 / Fibroblastos / Infarto do Miocárdio Limite: Animals Idioma: En Revista: JCI Insight Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Estados Unidos